GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

11 hedge funds and large institutions have $1.14M invested in Amplify Treatments, Testing and Advancements ETF in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$132K
2
+$8.14K
3
+$3.72K

Top Sellers

1
-$3.63M
2
-$203K
3
-$34.2K
4
Citadel Advisors
Citadel Advisors
Florida
-$4.03K
5
Morgan Stanley
Morgan Stanley
New York
-$88
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$761K
2
$298K
3
$27.4K
4
$18.2K
5
$7.44K
6
$7.36K
7
$7.25K
8
$5.7K
9
$4.25K
10
$2.94K
11
–
12
–
13
–
14
–